We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A review of MDMA (‘ecstasy’), its harms and classification under the Misuse of Drugs Act 1971 (2009). The Advisory Council on the Misuse of…
Occupations, career history and interests of the members of the Advisory Council on the Misuse of Drugs (ACMD).
Report from the ACMD providing advice to the government on the changing age profile of people accessing drug treatment and the challenges faced by this cohort in the UK.
'Ketamine: a review of use and harm' provides advice from the Advisory Council on the Misuse of Drugs to the Home Secretary.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
The Advisory Council on the Misuse of Drugs (ACMD) has today (12 March) published a major report on powdered cocaine and its impact on British society.
This series brings together all documents relating to ACMD inquiry reports
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
The Advisory Council on the Misuse of Drugs (ACMD) has provided advice on the scheduling of nitrous oxide.
The government responds to a report by the Advisory Council on the Misuse of Drugs and commissions Part 2 of work on barriers to research.
Report from the Advisory Council on the Misuse of Drugs (ACMD) on consumer cannabidiol (CBD) products.
Advice on preventing drug misuse among vulnerable groups of people, with a focus on understanding factors that contribute to vulnerability.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
An assessment of the impact of rescheduling CBPMs to Schedule 2 under the Misuse of Drugs Regulations 2001 (MDR) and recommendations to mitigate the issues identified.
This series brings together all documents relating to ACMD annual reports
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
The Advisory Council on the Misuse of Drugs has recommended the control of three prescription medicines
ACMD public request for written evidence on cognition enhancers (also known as ‘nootropics’ or ‘study drugs’).
These ACMD letters to Minister for Crime Prevention, Jeremy Browne MP advise on lisdexamfetamine and z-drugs.
Independent report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the risk factors to substance use-related problems and harms.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.